This case study demonstrates how MedPharm stabilized a biologic formulation for topical nail delivery by identifying root causes of instability and optimizing excipient selection. Through targeted degradation studies and formulation optimization, MedPharm improved stability, reduced development risk, and enabled progression to IND-enabling studies.
